Business

Emergent Health Appoints Former Vice-President and Director of Enzolytics, James Zimbler as Chief Executive Officer

Emergent Health Appoints Former Vice-President and Director of Enzolytics, James Zimbler as Chief Executive Officer.

articleEmergent Health Corp.February 9, 20223/company/emergent-health-corp/news/emergent-health-appoints-former-vice-president-and-director-of-enzolytics-james-zimbler-as-chief-executive-officer
Emergent Health Appoints Former Vice-President and Director of Enzolytics, James Zimbler as Chief Executive Officer

About this update from Emergent Health Corp.

[{"type":"text","content":"KING OF PRUSSIA, PA / ACCESSWIRE / February 9, 2022 / Emergent Health Corp., (OTC PINK:EMGE) announces the appointment of James Zimbler as Chief Executive Officer to replace Frank Magliochetti.From November 2017, Mr. Zimbler has served in various roles at Cannagistics, Inc. ("CNGT"), a developer of an extensive portfolio of consumer products, which include FDA cleared, patented, patent pending diverse product lines, that capitalize on disruptive delivery systems in the areas of pain relief, pharmaceuticals, skincare, nutraceuticals and agricultural/veterinary products responsible for strategic decision making, capital expenditure planning and staffing matters. From March 2017 until June 2019, Mr. Zimbler served as a Vice-President and Director of Enzolytics, Inc. ("ENZC"), a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. He is also a founder and developer of Availa Bio, Inc., a developer of regenerative medicine health hand wellness products and cosmetics and anti-aging products, including the Dr. Denese Brand, sold on QVC.In December 2016 he founded Emerging Growth Advisors, Inc., a consulting firm providing advisory services related to mergers and acquisitions for corporations including the Company, where he has served as President since its formation.Mr. Magliochetti's resignation was due to other business interests which are a priority at this time. Mr. Magliochetti shall remain a Consultant to Emergent.James Zimbler, newly appointed CEO of Emergent, stated, "I regret that I will not have had my much-anticipated chance to work with the recently-passed Dr. John Cappello. However, a new opportunity has been placed before me: carry on his passion for, and commitment to, EMGE's mission. And I am extremely excited for the opportunity to lead the Emergent Health team into the future, as we implement the plans for expanding our current footprint in the nutritional supplement marketplace, as well as for our recently-acquired Pharmazu's becoming a force in the pet pharmacy, vet telehealth and pet wellness businesses." Mr. Zimbler continued, "I am confident that the combination of my experience in the bio-wellness and pet bio-wellness industries and the existing EMGE/Pharmazu team will bring positive resul...

More updates from Emergent Health Corp.